Early response to upfront neoadjuvant chemotherapy (CAPOX) alone in low- and intermediate-risk rectal cancer: a single-arm phase II trial

BACKGROUND: With local recurrence of rectal cancer continuing to decrease, distant recurrence is becoming a major concern, especially for patients with low- and intermediate-risk stage II/III rectal cancer. Therefore, a new treatment strategy is warranted for these patients. This single-arm phase II...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Xiangbing, Wu, Qingbin, Bi, Liang, Yu, Yongyang, Huang, Shuo, He, Du, Wu, Bing, Gou, Hongfeng, Meng, Wenjian, Qiu, Meng, He, Yazhou, Wang, Ziqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364694/
https://www.ncbi.nlm.nih.gov/pubmed/34792107
http://dx.doi.org/10.1093/bjs/znab388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364694/
https://www.ncbi.nlm.nih.gov/pubmed/34792107
http://dx.doi.org/10.1093/bjs/znab388

Ejemplares similares